220 related articles for article (PubMed ID: 8105477)
1. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.
Mock BA; Krall MM; Dosik JK
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9499-503. PubMed ID: 8105477
[TBL] [Abstract][Full Text] [Related]
2. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
3. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
[TBL] [Abstract][Full Text] [Related]
4. Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice.
Beecham EJ; Owens JD; Shaughnessy JD; Huppi K; Bohr VA; Mushinski JF
Carcinogenesis; 1997 Apr; 18(4):687-94. PubMed ID: 9111201
[TBL] [Abstract][Full Text] [Related]
5. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4.
Mock BA; Hartley J; Le Tissier P; Wax JS; Potter M
Blood; 1997 Nov; 90(10):4092-8. PubMed ID: 9354679
[TBL] [Abstract][Full Text] [Related]
6. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
McDonald AH; Degrassi A
Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
[TBL] [Abstract][Full Text] [Related]
7. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S; Ramsay ES; Mock BA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
[TBL] [Abstract][Full Text] [Related]
8. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
[TBL] [Abstract][Full Text] [Related]
9. Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice.
Potter M; Hartley JW; Wax JS; Gallahan D
J Exp Med; 1984 Aug; 160(2):435-40. PubMed ID: 6088663
[TBL] [Abstract][Full Text] [Related]
10. DNA repair defects associated with chromosomal translocation breaksite regions.
Beecham EJ; Jones GM; Link C; Huppi K; Potter M; Mushinski JF; Bohr VA
Mol Cell Biol; 1994 Feb; 14(2):1204-12. PubMed ID: 8289801
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice.
Hilbert DM; Pumphrey JG; Troppmair J; Rapp UR; Rudikoff S
Oncogene; 1993 Jul; 8(7):1993-2000. PubMed ID: 7685514
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
Potter M; Wiener F
Carcinogenesis; 1992 Oct; 13(10):1681-97. PubMed ID: 1423827
[TBL] [Abstract][Full Text] [Related]
13. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
Potter M; Wax JS; Hansen CT; Kenny JJ
Int Immunol; 1999 Jul; 11(7):1059-64. PubMed ID: 10383938
[TBL] [Abstract][Full Text] [Related]
14. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations.
Wiener F; Babonits M; Bregula U; Klein G; Léonard A; Wax JS; Potter M
J Exp Med; 1984 Jan; 159(1):276-91. PubMed ID: 6607313
[TBL] [Abstract][Full Text] [Related]
15. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
Wiener F; Coleman A; Mock BA; Potter M
Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
[TBL] [Abstract][Full Text] [Related]
16. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
Bliskovsky V; Ramsay ES; Scott J; DuBois W; Shi W; Zhang S; Qian X; Lowy DR; Mock BA
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14982-7. PubMed ID: 14634209
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
[TBL] [Abstract][Full Text] [Related]
18. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
Müller JR; Jones GM; Potter M; Janz S
Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601
[TBL] [Abstract][Full Text] [Related]
19. Two major interacting chromosome loci control disease susceptibility in murine model of spondyloarthropathy.
Végvári A; Szabó Z; Szántó S; Nesterovitch AB; Mikecz K; Glant TT; Adarichev VA
J Immunol; 2005 Aug; 175(4):2475-83. PubMed ID: 16081819
[TBL] [Abstract][Full Text] [Related]
20. Multigenic control of skin tumor susceptibility in SENCARA/Pt mice.
Mock BA; Lowry DT; Rehman I; Padlan C; Yuspa SH; Hennings H
Carcinogenesis; 1998 Jun; 19(6):1109-15. PubMed ID: 9667751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
